{"id":"cyclo-progynova","safety":{"commonSideEffects":[{"rate":null,"effect":"Breast tenderness"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Nausea"},{"rate":null,"effect":"Vaginal bleeding/spotting"},{"rate":null,"effect":"Fluid retention"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"The drug delivers alternating doses of estradiol (estrogen) and norgestrel (progestin) in a 21-day cycle to mimic natural hormonal fluctuations. This cyclical regimen helps alleviate vasomotor symptoms (hot flashes, night sweats) and other menopausal symptoms while providing endometrial protection through the progestin component.","oneSentence":"Cyclo-Progynova is a cyclical hormone replacement therapy combining estrogen and progestin to replace declining hormones in menopausal women.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:08:20.688Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Menopausal vasomotor symptoms (hot flashes, night sweats)"},{"name":"Menopausal genitourinary symptoms"},{"name":"Osteoporosis prevention in postmenopausal women"}]},"trialDetails":[{"nctId":"NCT07013643","phase":"PHASE1","title":"A Study to Investigate the Effect of AZD6234, AZD9550, and a Combination of AZD9550 and AZD6234 on Pharmacokinetics of Combined Oral Contraceptive Ethinyl Estradiol/Levonorgestrel in Healthy Female Participants Living With Overweight or Obesity","status":"RECRUITING","sponsor":"AstraZeneca","startDate":"2025-06-04","conditions":"Healthy Participants","enrollment":75},{"nctId":"NCT07288190","phase":"PHASE2","title":"Phase 2b, Open Label, Multisite, Randomized Crossover Study of DPP Versus 2PR","status":"NOT_YET_RECRUITING","sponsor":"HIV Prevention Trials Network","startDate":"2026-05-15","conditions":"Pregnancy, HIV Infections","enrollment":300},{"nctId":"NCT06942936","phase":"PHASE1","title":"A Study to Investigate the Impact of Multiple Doses of Itraconazole on AZD5004 in Healthy Participants and Multiple Doses of AZD5004 on Combined Oral Ethinyl Oestradiol and Levonorgestrel in Healthy Female Participants","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2025-05-28","conditions":"Healthy Participants","enrollment":51},{"nctId":"NCT07338955","phase":"","title":"Validating and Assessing Reliability","status":"RECRUITING","sponsor":"Bahria University","startDate":"2025-11-03","conditions":"Upper Limb Disability","enrollment":385},{"nctId":"NCT07272889","phase":"PHASE1","title":"Drug-drug Interaction Study of Bemnifosbuvir/Ruzasvir (BEM/RZR) and Ethinyl Estradiol/Levonorgestrel (EE/LNG)","status":"NOT_YET_RECRUITING","sponsor":"Atea Pharmaceuticals, Inc.","startDate":"2025-12","conditions":"Healthy Volunteer Study","enrollment":24},{"nctId":"NCT06354257","phase":"PHASE1","title":"A Study to Investigate the Pharmacokinetics of a Combined Oral Contraceptive When Given Alone and in Combination With GSK3036656 in Female Participants of Non-childbearing Potential Aged 18 to 65 Years of Age","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2024-04-05","conditions":"Tuberculosis","enrollment":20},{"nctId":"NCT06455969","phase":"PHASE4","title":"Adaptions and Resiliency to Multi-Stressor OpeRations","status":"RECRUITING","sponsor":"Bradley Nindl","startDate":"2024-07-15","conditions":"Musculoskeletal Injury, Hypogonadism","enrollment":120},{"nctId":"NCT06186271","phase":"","title":"International Active Surveillance Study: Safety of Estrogen Estetrol (E4) Contraceptive Study (INAS-SEECS)","status":"RECRUITING","sponsor":"Center for Epidemiology and Health Research, Germany","startDate":"2025-04-24","conditions":"Contraception","enrollment":68100},{"nctId":"NCT06028555","phase":"","title":"International Active Surveillance Study: Native Estrogen Estetrol (E4) Safety Study","status":"RECRUITING","sponsor":"Center for Epidemiology and Health Research, Germany","startDate":"2023-06-28","conditions":"Contraception, Birth Control","enrollment":101000},{"nctId":"NCT03249402","phase":"PHASE1","title":"A Study to Evaluate the Effect of Multiple Oral Doses of JNJ-42847922 on the Steady-state Pharmacokinetics of an Oral Contraceptive Containing Ethinyl Estradiol and Levonorgestrel in Healthy Female Adult Participants","status":"COMPLETED","sponsor":"Janssen-Cilag International NV","startDate":"2017-08-14","conditions":"Healthy","enrollment":24},{"nctId":"NCT06671405","phase":"PHASE1","title":"An Open-label Study in Healthy Participants to Evaluate AZD0780 as an Object or Precipitant of CYP3A4-mediated Drug-drug Interactions","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2024-09-25","conditions":"Dyslipidaemia","enrollment":59},{"nctId":"NCT05896384","phase":"PHASE1","title":"A Study in Women With Overweight or Obesity to Test Whether Different Doses of BI 456906 Influence the Amount of a Contraceptive in the Blood","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2023-12-21","conditions":"Healthy","enrollment":32},{"nctId":"NCT06799884","phase":"PHASE1","title":"A Drug-drug Interaction Trial in Healthy Female Participants to Investigate the Effect of Aprocitentan on Combined Hormonal Contraceptives","status":"COMPLETED","sponsor":"Idorsia Pharmaceuticals Ltd.","startDate":"2025-01-18","conditions":"Drug Drug Interaction","enrollment":19},{"nctId":"NCT06657105","phase":"PHASE1","title":"A Study to Investigate the Pharmacokinetics of Ethinyl Estradiol and Levonorgestrel When Given Alone and in Combination With Baxdrostat in Healthy Females of Non-childbearing Potential","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2024-11-01","conditions":"Healthy Participants","enrollment":22},{"nctId":"NCT03557619","phase":"PHASE1","title":"A Study to Assess the Effect of Venetoclax on Ethinyl Estradiol and Levonorgestrel in Female Participants With Different Hematological Malignancies","status":"RECRUITING","sponsor":"AbbVie","startDate":"2019-07-30","conditions":"Hematologic Malignancies","enrollment":12},{"nctId":"NCT03745144","phase":"PHASE1","title":"Effects of Cladribine Tablets on the PK of Microgynon®","status":"COMPLETED","sponsor":"Merck KGaA, Darmstadt, Germany","startDate":"2019-01-17","conditions":"Relapsing Multiple Sclerosis (RMS)","enrollment":28},{"nctId":"NCT05153564","phase":"PHASE1","title":"A Research Study Looking Into the Effect of Semaglutide and NNC0480 0389 on Blood Levels of a Birth Control Pill in Woman After Menopause","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2021-12-13","conditions":"Diabetes Mellitus, Type 2","enrollment":27},{"nctId":"NCT05613777","phase":"PHASE1","title":"A Study in Healthy Women to Test Whether BI 425809 Influences the Amount of a Contraceptive in the Blood","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2022-11-24","conditions":"Healthy","enrollment":19},{"nctId":"NCT05244811","phase":"PHASE3","title":"Treat of Functional Ovarian Cysts by Compare Between Cocs and Progesterone Only Pills","status":"UNKNOWN","sponsor":"Sohag University","startDate":"2022-02-20","conditions":"Ovarian Neoplasms","enrollment":60},{"nctId":"NCT04537078","phase":"PHASE3","title":"Progestin Primed Double Stimulation Protocol Versus Flexible GnRH Antagonist Protocol in Poor Responders","status":"COMPLETED","sponsor":"El Shatby University Hospital for Obstetrics and Gynecology","startDate":"2020-09-01","conditions":"Infertility, Female","enrollment":90},{"nctId":"NCT00511355","phase":"PHASE3","title":"Effects on Hemostasis, Lipids, Carbohydrate Metabolism, Adrenal & Thyroid Function of the Combined Oral Contraceptive NOMAC-E2 Compared to a COC Containing LNG-EE (292004)(COMPLETED)(P05764)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-10","conditions":"Contraception","enrollment":121},{"nctId":"NCT01044056","phase":"PHASE4","title":"A Trial in Healthy Female Subjects to Compare the Pharmacokinetics of Ethinyl Estradiol of NuvaRing®, a Contraceptive Patch (EVRA(TM)) and an Oral Contraceptive (Microgynon® 30) (Study 34237 (P06650)) (COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2004-03","conditions":"Contraception","enrollment":24},{"nctId":"NCT02393482","phase":"PHASE4","title":"Psychological Impact of Amenorrhea in Women With Endometriosis","status":"UNKNOWN","sponsor":"University of Cagliari","startDate":"2021-06","conditions":"Amenorrhea, Endometriosis, Quality of Life","enrollment":50},{"nctId":"NCT03675581","phase":"PHASE1","title":"A Study to Test Whether Nintedanib Influences the Components of Birth-control Pills in Women With Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD)","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2018-11-08","conditions":"Scleroderma, Systemic","enrollment":17},{"nctId":"NCT00662454","phase":"PHASE4","title":"Oral Contraceptive Efficacy and Body Weight","status":"COMPLETED","sponsor":"Oregon Health and Science University","startDate":"2006-01","conditions":"Contraception, Body Weight","enrollment":120},{"nctId":"NCT04142762","phase":"PHASE1","title":"A Study to Assess CYP3A4 Modulator, Oral Contraceptive, and pH Modifier Drug Interactions for ABI-H2158 in Healthy Adults","status":"COMPLETED","sponsor":"Assembly Biosciences","startDate":"2019-10-18","conditions":"Chronic Hepatitis B","enrollment":80},{"nctId":"NCT04247204","phase":"NA","title":"Assessment of Endometrial and Sub-endometrial Vascularity Before and After PRP Infusion in Frozen Embryo Transfer Cycles","status":"UNKNOWN","sponsor":"Hatem AbuHashim","startDate":"2020-02-08","conditions":"Frozen Embryo Transfer","enrollment":30},{"nctId":"NCT02475265","phase":"PHASE2","title":"Transdermal Estrogen in Older Premenopausal Women With Anorexia Nervosa","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2015-07","conditions":"Anorexia Nervosa, Osteoporosis","enrollment":11},{"nctId":"NCT02531321","phase":"PHASE4","title":"Protease Inhibitors and Combined Oral Contraceptive Pharmacokinetics and Pharmacodynamics","status":"TERMINATED","sponsor":"University of Southern California","startDate":"2015-08","conditions":"Contraception, HIV","enrollment":17},{"nctId":"NCT02751385","phase":"PHASE1","title":"Investigation of the Effect of Nintedanib on the Pharmacokinetics of a Combination of Ethinylestradiol and Levonorgestrel in Patients With Non-small Cell Lung Cancer","status":"TERMINATED","sponsor":"Boehringer Ingelheim","startDate":"2016-05-20","conditions":"Carcinoma, Non-Small-Cell Lung","enrollment":2},{"nctId":"NCT03210246","phase":"PHASE1","title":"Drug-drug Interaction Study: Influence of Vilaprisan on Pharmacodynamics (PD) and Pharmacokinetics (PK) of a Combined Oral Contraceptive (COC)","status":"COMPLETED","sponsor":"Bayer","startDate":"2017-07-17","conditions":"Clinical Trial ,Phase I","enrollment":71},{"nctId":"NCT03788681","phase":"PHASE3","title":"Luteal Phase Support With Estradiol In Poor Responders Undergoing In Vitro Fertilization","status":"UNKNOWN","sponsor":"Ain Shams University","startDate":"2018-04-01","conditions":"ICSI","enrollment":170},{"nctId":"NCT03301233","phase":"NA","title":"Effect Sildenafil and Estradiiol Valerate on Endometrial Thickness in Infertile Women","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2017-11-01","conditions":"Endometrial Thickness","enrollment":90},{"nctId":"NCT01250210","phase":"PHASE2","title":"Evaluation of Pharmacodynamic Effects on Ovulation and Cycle Control","status":"COMPLETED","sponsor":"Agile Therapeutics","startDate":"2007-09","conditions":"Ovulation Suppression","enrollment":123},{"nctId":"NCT03506399","phase":"PHASE1","title":"A Study of Lanabecestat in Healthy Female Participants Taking Oral Contraceptive","status":"WITHDRAWN","sponsor":"Eli Lilly and Company","startDate":"2018-06","conditions":"Healthy","enrollment":""},{"nctId":"NCT02846142","phase":"PHASE1","title":"Study to Assess the Safety, Tolerability, PK, ECG Effects, Food Effect, and Drug-drug Interaction (DDI) of Hormonal Contraceptives of PTI-428 in Healthy Female Volunteers","status":"COMPLETED","sponsor":"Proteostasis Therapeutics, Inc.","startDate":"2016-06","conditions":"Healthy Volunteer","enrollment":94},{"nctId":"NCT01941134","phase":"PHASE4","title":"Changes in Oral Contraceptive Hormones After Gastric Bypass Surgery","status":"WITHDRAWN","sponsor":"Johns Hopkins University","startDate":"2013-04","conditions":"Bariatric Surgery Candidate, Contraception","enrollment":""},{"nctId":"NCT03359057","phase":"PHASE3","title":"Trial Evaluating Folic Acid Supplementation by Concomitant Administration of Ethinyl Estradiol + Levonorgestrel","status":"COMPLETED","sponsor":"Galeno Desenvolvimento de Pesquisas Clínicas","startDate":"2013-02-26","conditions":"Contraception","enrollment":36},{"nctId":"NCT03353883","phase":"PHASE2, PHASE3","title":"Early Preparation With Gonadotropin- Releasing Hormon (GnRh) Agonists Injection With Frozen-Thawed Embryo Transfer?","status":"UNKNOWN","sponsor":"Benha University","startDate":"2017-06-01","conditions":"Infertility, Female","enrollment":200},{"nctId":"NCT02845219","phase":"PHASE1","title":"A Trial Investigating the Influence of Oral Semaglutide on Pharmacokinetics of Ethinylestradiol and Levonorgestrel in an Oral Contraceptive Combination Drug in Healthy Postmenopausal Females","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2016-07","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":25},{"nctId":"NCT01896726","phase":"PHASE1","title":"A Study of Baricitinib and Birth Control Pills in Healthy Females","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2013-07","conditions":"Healthy Volunteers","enrollment":20},{"nctId":"NCT01546454","phase":"NA","title":"Relationship Between the Menstrual Cycle and Heart Disease in Women","status":"COMPLETED","sponsor":"Oregon Health and Science University","startDate":"2012-02","conditions":"Coronary Heart Disease","enrollment":5},{"nctId":"NCT01615354","phase":"PHASE1","title":"A Study of Aleglitazar in Combination With Oral Contraceptive Healthy Volunteers","status":"COMPLETED","sponsor":"Hoffmann-La Roche","startDate":"2012-07","conditions":"Healthy Volunteer","enrollment":18},{"nctId":"NCT00511784","phase":"","title":"Relative Risks for Non-fatal Venous Thromboembolism, Ischemic Stroke and Myocardial Infarction in Users of ORTHO EVRA(Norelgestromin and Ethinyl Estradiol Contraceptive Patch) Compared to Levonorgestrel-containing Oral Contraceptives.","status":"COMPLETED","sponsor":"Johnson & Johnson Pharmaceutical Research & Development, L.L.C.","startDate":"2006-11","conditions":"Contraception, Female Contraception, Fertility Control","enrollment":440},{"nctId":"NCT01941615","phase":"PHASE1","title":"Effect of BI 207127 + Faldaprevir on Blood Levels of Oral Contraceptives Containing Ethinylestradiol and Levonorgestrel","status":"TERMINATED","sponsor":"Boehringer Ingelheim","startDate":"2013-11","conditions":"Healthy","enrollment":18},{"nctId":"NCT02170038","phase":"PHASE1","title":"Clinical Study Investigating the Conversion of the Contraceptive Compound Norethisterone Within the Body Towards the Contraceptive Compound Ethinylestradiol","status":"COMPLETED","sponsor":"Bayer","startDate":"2014-06","conditions":"Pharmacokinetics","enrollment":16},{"nctId":"NCT01170390","phase":"PHASE4","title":"Oral Contraceptives and Body Mass Index","status":"COMPLETED","sponsor":"Oregon Health and Science University","startDate":"2009-09","conditions":"Body Weight, Contraceptive Usage","enrollment":32},{"nctId":"NCT00909857","phase":"PHASE3","title":"Effect on Primary Dysmenorrhea","status":"COMPLETED","sponsor":"Bayer","startDate":"2009-04","conditions":"Primary Dysmenorrhea","enrollment":507},{"nctId":"NCT02159326","phase":"PHASE1","title":"Microgynon Riociguat Drug Interaction Study in Healthy Postmenopausal Women","status":"COMPLETED","sponsor":"Bayer","startDate":"2014-06","conditions":"Drug Interactions","enrollment":31},{"nctId":"NCT02385448","phase":"PHASE4","title":"Comparing the Use of Dienogest and Combined Oral Contraceptive Pills (Microgynon) to Reduce the Risk of Recurrence of Endometriotic Cyst After Conservative Surgery","status":"UNKNOWN","sponsor":"The University of Hong Kong","startDate":"2015-02","conditions":"Endometriosis","enrollment":144},{"nctId":"NCT00764881","phase":"PHASE3","title":"Effects of SH T00658ID on Libido","status":"COMPLETED","sponsor":"Bayer","startDate":"2009-01","conditions":"Contraception, Libido","enrollment":217},{"nctId":"NCT00651846","phase":"PHASE4","title":"Investigate Impact of Yasmin vs Microgynon on Hemostasis Parameters in Healthy Women","status":"COMPLETED","sponsor":"Bayer","startDate":"2003-06","conditions":"Healthy","enrollment":43},{"nctId":"NCT00933179","phase":"PHASE2","title":"FC Patch Low: Metabolism Study","status":"COMPLETED","sponsor":"Bayer","startDate":"2009-06","conditions":"Contraception","enrollment":30},{"nctId":"NCT02175394","phase":"PHASE1","title":"Effect of Multiple BI 1356 Doses of on the Multiple-dose Pharmacokinetics of a Combination of Ethinylestradiol and Levonorgestrel in Healthy Female Premenopausal Subjects","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2008-07","conditions":"Healthy","enrollment":18},{"nctId":"NCT01328184","phase":"PHASE1","title":"Drug-drug Interaction of Empagliflozin (BI 10773) and Microgynon","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2011-04","conditions":"Healthy","enrollment":18},{"nctId":"NCT01297348","phase":"","title":"Study Of Lybrel In Relation To Venous Thromboembolism","status":"COMPLETED","sponsor":"Pfizer","startDate":"2007-07","conditions":"Venous Thrombosis, Pulmonary Embolism, Sinus Thrombosis, Intracranial","enrollment":598682},{"nctId":"NCT01569113","phase":"PHASE4","title":"Assessment of Effects on Ovarian Activity of a Combined Oral Contraceptive Pill When Preceded by the Intake of ellaOne® or Placebo.","status":"COMPLETED","sponsor":"HRA Pharma","startDate":"2012-03","conditions":"Emergency Contraception","enrollment":76},{"nctId":"NCT00570440","phase":"PHASE4","title":"Continuous Use of COCs","status":"COMPLETED","sponsor":"FHI 360","startDate":"2007-08","conditions":"Pregnancy Prevention","enrollment":362},{"nctId":"NCT00237042","phase":"NA","title":"Managing Temporomandibular Disorder (TMD) Symptoms","status":"COMPLETED","sponsor":"University of Washington","startDate":"2005-10","conditions":"Temporomandibular Joint Disorders","enrollment":252},{"nctId":"NCT00206622","phase":"PHASE4","title":"Efficacy and Safety Study in Postmenopausal Women to Determine the Lowest Effective Dose for Relief of Moderate to Severe Hot-Flushes","status":"COMPLETED","sponsor":"Bayer","startDate":"2004-12","conditions":"Hot Flashes","enrollment":425},{"nctId":"NCT00006324","phase":"NA","title":"Hormonal Birth Control and the Risk of Acquiring HIV","status":"COMPLETED","sponsor":"Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)","startDate":"1999-12","conditions":"HIV Infections","enrollment":6360}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":6,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Cyclo-Progynova","genericName":"Cyclo-Progynova","companyName":"El Shatby University Hospital for Obstetrics and Gynecology","companyId":"el-shatby-university-hospital-for-obstetrics-and-gynecology","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Cyclo-Progynova is a cyclical hormone replacement therapy combining estrogen and progestin to replace declining hormones in menopausal women. Used for Menopausal vasomotor symptoms (hot flashes, night sweats), Menopausal genitourinary symptoms, Osteoporosis prevention in postmenopausal women.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}